about
Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimeraSuppression of cell growth and invasion by miR-205 in breast cancerInteraction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulinNeuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labellingEssential function for ErbB3 in breast cancer proliferationTyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinasesTargeting of erbB3 receptor to overcome resistance in cancer treatmentRegulation of ERBB3/HER3 signaling in cancerPhosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cellsTransformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factorChromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastasesEpithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell linesChanges in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cellsErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactationTumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cellsThe ErbB signaling network: receptor heterodimerization in development and cancerSimultaneous profiling of 194 distinct receptor transcripts in human cellsExpression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry.Episomally mediated overexpression of wild-type erbB-2 transforms MCF-10A breast epithelial cells.Neuregulins 1-4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast.Expression and function of heregulin-alpha and its receptors in the mouse mammary gland.Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)c-erbB3 protein expression in ovarian cancer.Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancerGenetic analysis of breast cancer progression.Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.The epidermal growth factor receptor family in breast cancer.The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisThe significance of immunohistochemistry in the diagnosis and therapy of neoplasms.The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.Targeting miR-205 in breast cancer.Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
P2860
Q24309266-8D05BAC1-D488-4378-B989-69DA7B25D0BBQ24319261-042C0890-880E-4F1C-8F3F-55690678EDA2Q24595150-C10953DC-F789-4709-B0C8-E7552C5881B7Q24647586-4F64B414-1006-4F89-910A-531210CC9D0AQ24649294-7D2AB64A-56C8-4858-9C64-530BE1D6C277Q24681497-5765EA60-2E92-4B48-922F-4650501574CAQ24794988-FC99FF9E-5732-4CDC-B8B9-0E698F101F68Q24795054-9C9C7C46-0A51-4BF6-AD7C-16BFCCB3D15EQ24802950-3B5CC608-4E3D-4BFC-B25C-21CEE9A0EFF0Q26864668-63D1C891-9B27-48A2-9399-1F930B24AAD2Q27024334-2B4B80AB-E47B-4A22-B50A-78AF6EBF912FQ28269146-A8CD1DFB-DE51-41E4-AC4F-FF9579FB842AQ28279061-CCB6E260-0381-4A24-8D6E-B5E14BB815DDQ28298083-137D66CC-6795-46C0-BAD1-75C3D4959EB8Q28345662-B234826C-E155-44E5-8301-E024FC5E668CQ28484892-3AE0B814-C17A-4663-8FF4-0E1151C2BBA3Q28582442-2DFDA6CC-A4C4-401A-8577-0DBE7626FFA7Q28594099-B74A7946-6F27-48D6-8972-AF52DB72BFF2Q28609073-375C622A-492A-4347-A663-CC35E5D1619FQ28678816-72589018-26A6-4A6C-8A92-389D7D6262F0Q29617919-D3AE3DAC-4564-4590-8B6D-551CF1A92C74Q30411399-CEFA8702-15E0-42B2-BD88-966957FE5FC4Q30760935-63271783-E9EB-4510-8F3D-58B5A5AF6067Q30872511-BA09DA97-FF98-4C0B-A826-24EF1A61F0F8Q33226349-5B4291AA-8E58-4D75-9F07-45576CAE3EC4Q33686043-E5967D3F-CB5E-4F97-9C00-260136CE2842Q33739278-09A7C9A1-011F-412D-8F7D-88AAE4FBC078Q33772914-868902D1-EBB0-4D6A-963D-C55795722357Q33841195-CBEFD51D-59BA-498F-92B4-B7E7B5391208Q33890758-09A2BAFB-755B-446E-A816-A664DC69C5E3Q33962744-28C07818-25B4-48CE-BF5A-3F2A2228324CQ34121278-B9BA75D6-F9A5-4F17-991E-68E0A56F9B7DQ34363400-8D02C9F2-E2FB-4670-A5CC-A32EE0E27E73Q34493341-A0BE0079-6E51-422E-ACEF-33445ADB500EQ34602545-F6D41A6A-383D-40A5-AB4A-9E6124B4DC14Q34725896-06C63135-9CB4-48ED-8063-83416C1D8875Q35008487-71E68BB9-96FF-449F-829C-6AD9686BD11BQ35558954-4735EFCB-AD51-4BF5-A9ED-3F8312019490Q35586732-CD9BE064-7A04-4974-80E2-21CE8B2A6C8FQ35683561-0CD27F7A-D5E9-438C-B103-1047835B9628
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Expression of the ERBB3 gene product in breast cancer.
@ast
Expression of the ERBB3 gene product in breast cancer.
@en
type
label
Expression of the ERBB3 gene product in breast cancer.
@ast
Expression of the ERBB3 gene product in breast cancer.
@en
prefLabel
Expression of the ERBB3 gene product in breast cancer.
@ast
Expression of the ERBB3 gene product in breast cancer.
@en
P2093
P2860
P356
P1476
Expression of the ERBB3 gene product in breast cancer.
@en
P2093
Gullick WJ
Hollywood DP
Lemoine NR
Prigent SA
P2860
P2888
P304
P356
10.1038/BJC.1992.420
P407
P577
1992-12-01T00:00:00Z
P5875
P6179
1006183819